Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer.

MLA

Al-Rajabi, Taiseer, et al. “Editorial: Optimizing Outcomes and Addressing Adversities of Immunotherapy in Lung Cancer.” Frontiers in Oncology, Sept. 2023, pp. 1–4. EBSCOhost, https://doi.org/10.3389/fonc.2023.1277542.

APA

Al-Rajabi, T., Naidoo, J., & Jun Zhang. (2023). Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer. Frontiers in Oncology, 1–4. https://doi.org/10.3389/fonc.2023.1277542

Chicago

Al-Rajabi, Taiseer, Jarushka Naidoo, and Jun Zhang. 2023. “Editorial: Optimizing Outcomes and Addressing Adversities of Immunotherapy in Lung Cancer.” Frontiers in Oncology, September, 1–4. doi:10.3389/fonc.2023.1277542.